Intercept Pharmaceuticals competitive analysis

Explore Intercept Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
Nov 2, 2022Methods Of Promoting Hepatic Regeneration3
Nov 17, 2021Pharmaceutical Compositions For Combination Therapy1
Sep 22, 2021Film-Coated Tablet Having High Chemical Stability Of Active Ingredient1
Nov 18, 2020Treatment Of Fibrosis Using Fxr Ligands1
Dec 31, 2014Treatment Of Fibrosis Using Fxr Ligands1

Latest PTAB cases involving Intercept Pharmaceuticals

Discover the latest PTAB cases involving Intercept Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Intercept Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INTERCEPT PHARMACEUTICALS - 7 - -
GEORG KALHAMMER/STEPHAN TEIPEL15 - - -
HAMM&WITTKOPP PATENTANWÄLTE PARTMBB82 - - -
SANDOZ1492619 -